Cytogenix (fka CYGX)

[wanaB]

Kan,

Couldn't agree with you more. What would really substantiate this year's end report is more real news in the progress area as far as goals in the sales or licensing of the synDNA. That is their only real means of revenue and needs to be pushed at this time to show that they can be somewhat self sufficient. At least that is my thinking. But I'm no Einstein and that should be pretty obvious.

What I didn't like about the report is the lack of mention of Aldevron's second round of testing which I would think would have to be somewhat close to done...if what was reported mid last year was the truth.

The report also illudes to the fact that there is much news and progress reports that are right around the corner. This has been stated before and empty results here could be devistating IMHO.

I hope stonehenge or whomever can accomplish the job put forth. I'm not really ecstatic aboout our DD's have turned up virtually nada on the company. Poor results and keeping word right now is paramount. I think all will be well in the future but the company is very fragile right now and walking on thin ice.

JMHO

wannaB